Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin International Joint Research and Development Centre of Ophthalmology and Vision Science, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.
Binhai Hospital of Tianjin Medical University General Hospital, Tianjin, China.
Eur J Ophthalmol. 2021 Nov;31(6):3099-3109. doi: 10.1177/1120672120977359. Epub 2020 Nov 30.
To evaluate the factors related to sympathetic ophthalmia (SO) in a series of patients in our ophthalmology center and previously published cases.
A retrospective and noncomparative review was performed on 16 patients with SO attending our ophthalmology center from 2013 to 2019. A total of 87 previously published cases of SO were identified by searching the Medline database from 2009 to 2019.
Sixteen patients were included in the analysis, and six cases were induced by transscleral cyclophotocoagulation (TCP). All patients had achieved controlled inflammation at their last follow-up visit. Thirteen patients (81.3%) had improved best-corrected visual acuity (BCVA). A review of the literature revealed 87 previously reported cases of SO. Shared clinical features and treatment outcomes were summarized.
Ocular therapies, including both penetrating ocular therapy and non-penetrating ocular intervention, have become increasingly prevalent risk factors for SO, and the latent period has increased compared to past reports. Visual prognosis with appropriate medical management is relatively good.
评估我院眼科中心一系列患者及既往已发表病例中与交感眼炎（SO）相关的因素。
对 2013 年至 2019 年在我院眼科中心就诊的 16 例 SO 患者进行回顾性非对照研究。通过 2009 年至 2019 年在 Medline 数据库中检索，共确定了 87 例既往发表的 SO 病例。
分析纳入 16 例患者，其中 6 例由经巩膜睫状体光凝术（TCP）诱发。所有患者在最后一次随访时炎症均得到控制。13 例（81.3%）患者最佳矫正视力（BCVA）得到改善。文献复习共发现 87 例既往报道的 SO 病例。总结了这些病例的共同临床特征和治疗结果。
包括穿透性眼部治疗和非穿透性眼部干预在内的眼部治疗已成为 SO 的日益普遍的危险因素，与以往报告相比潜伏期有所增加。适当的药物治疗可获得较好的视力预后。
Zotero 插件